No abstract available
Keywords:
BRCA1 mutation; Immune checkpoint inhibitors; Predictive biomarkers; Renal cell carcinoma.
MeSH terms
-
Aged
-
Antineoplastic Agents, Immunological / administration & dosage*
-
Antineoplastic Agents, Immunological / adverse effects
-
BRCA1 Protein / genetics*
-
Carcinoma, Renal Cell / drug therapy*
-
Carcinoma, Renal Cell / genetics
-
Germ-Line Mutation
-
Humans
-
Kidney Neoplasms / drug therapy*
-
Kidney Neoplasms / genetics
-
Male
-
Neoplasm Metastasis
-
Nivolumab / administration & dosage*
-
Nivolumab / adverse effects
-
Precision Medicine
Substances
-
Antineoplastic Agents, Immunological
-
BRCA1 Protein
-
BRCA1 protein, human
-
Nivolumab